Atlas Trials

Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation

Clinical trial NCT02741856 · UNKNOWN

Trial details

NCT number
NCT02741856
Sponsor
Lisette Nixon
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Oesophageal Cancer
Start date
2016-11-04
Primary completion
2021-04-01
Enrollment
584

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.